Hypoxic regulation of vascular endothelial growth factor in retinal cells - PubMed (original) (raw)
Hypoxic regulation of vascular endothelial growth factor in retinal cells
L P Aiello et al. Arch Ophthalmol. 1995 Dec.
Abstract
Background: Vascular endothelial growth factor (VEGF) is an angiogenic protein and vasopermeability factor whose intraocular concentrations are closely correlated with active neovascularization in patients with diabetes mellitus, central retinal vein occlusion, retinopathy of prematurity, and rubeosis iridis.
Objective: To determine whether hypoxia could induce expression of VEGF in retinal cells, which then promotes retinal endothelial cell proliferation.
Methods: Retinal pigment epithelial cells, pericytes, and microvascular endothelial cells were exposed to hypoxic conditions in vitro, and RNA expression of VEGF was evaluated by Northern blot analysis. The VEGF-specific proliferative potential of the medium was measured by means of retinal endothelial cell growth assays and VEGF-neutralizing VEGF receptor IgG chimeric protein.
Results: The VEGF RNA levels increased within 4 hours and reached elevations of threefold to 30-fold after 18 hours of hypoxia (0% to 5% oxygen, 5% carbon dioxide, 90% to 95% nitrogen) in all cell types (.01 < P < .03). Stimulation was dependent on oxygen concentration. The VEGF RNA levels were normalized by reinstitution of normoxia for 24 hours (P < .004). Medium conditioned by hypoxic retinal pericytes and retinal pigment epithelial cells stimulated retinal endothelial cell growth by 20% (P = .04), and this stimulation was entirely inhibited by VEGF-neutralizing receptor chimeric protein (P = .02).
Conclusion: Hypoxia increases VEGF expression in retinal cells, which promotes retinal endothelial cell proliferation, suggesting that VEGF plays a major role in mediating intraocular neovascularization resulting from ischemic retinal diseases.
Similar articles
- Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells.
Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP. Takagi H, et al. Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2165-76. Invest Ophthalmol Vis Sci. 1996. PMID: 8843903 - Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells.
Suzuma K, Takagi H, Otani A, Honda Y. Suzuma K, et al. Invest Ophthalmol Vis Sci. 1998 May;39(6):1028-35. Invest Ophthalmol Vis Sci. 1998. PMID: 9579483 - Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.
Punglia RS, Lu M, Hsu J, Kuroki M, Tolentino MJ, Keough K, Levy AP, Levy NS, Goldberg MA, D'Amato RJ, Adamis AP. Punglia RS, et al. Diabetes. 1997 Oct;46(10):1619-26. doi: 10.2337/diacare.46.10.1619. Diabetes. 1997. PMID: 9313759 - Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF).
Sueishi K, Hata Y, Murata T, Nakagawa K, Ishibashi T, Inomata H. Sueishi K, et al. Pol J Pharmacol. 1996 May-Jun;48(3):307-16. Pol J Pharmacol. 1996. PMID: 9112668 Review. - Pitfalls in the measurement of circulating vascular endothelial growth factor.
Jelkmann W. Jelkmann W. Clin Chem. 2001 Apr;47(4):617-23. Clin Chem. 2001. PMID: 11274009 Review.
Cited by
- Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion.
Wang J, Li Y, Fang SF, Wang H. Wang J, et al. BMC Ophthalmol. 2020 Jul 9;20(1):274. doi: 10.1186/s12886-020-01544-4. BMC Ophthalmol. 2020. PMID: 32646391 Free PMC article. - Ocular complications of diabetes mellitus.
Sayin N, Kara N, Pekel G. Sayin N, et al. World J Diabetes. 2015 Feb 15;6(1):92-108. doi: 10.4239/wjd.v6.i1.92. World J Diabetes. 2015. PMID: 25685281 Free PMC article. Review. - Alterations in the Choroidal Sublayers in Relationship to Severity and Progression of Diabetic Retinopathy: A Swept-Source OCT Study.
Kung EWT, Chan VTT, Tang Z, Yang D, Sun Z, Wang YM, Chan CH, Kwan MCH, Shi J, Cheung CY. Kung EWT, et al. Ophthalmol Sci. 2022 Feb 25;2(2):100130. doi: 10.1016/j.xops.2022.100130. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249687 Free PMC article. - Attenuation of choroidal neovascularization by histone deacetylase inhibitor.
Chan N, He S, Spee CK, Ishikawa K, Hinton DR. Chan N, et al. PLoS One. 2015 Mar 25;10(3):e0120587. doi: 10.1371/journal.pone.0120587. eCollection 2015. PLoS One. 2015. PMID: 25807249 Free PMC article. - Systemic and Ocular Determinants of Choroidal Structures on Optical Coherence Tomography of Eyes with Diabetes and Diabetic Retinopathy.
Kinoshita T, Imaizumi H, Shimizu M, Mori J, Hatanaka A, Aoki S, Miyamoto H, Iwasaki M, Murao F, Niki M, Sano H, Sonoda S, Sakamoto T, Mitamura Y. Kinoshita T, et al. Sci Rep. 2019 Nov 7;9(1):16228. doi: 10.1038/s41598-019-52750-0. Sci Rep. 2019. PMID: 31700083 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources